Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Lobbyist name (consultant or in-house lobbyist): EL-REFAIE, FARIS OR;
  2. Responsible officer name: EL-REFAIE, FARIS
Share this search Create an alert
Start over
Modify criteria

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (7)
Results: 1-7 | Export
  1. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 48 of 64 (2022-02-16 to 2022-07-18)
    Posted: 2022-02-16
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  2. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 47 of 64 (2021-11-04 to 2022-02-16)
    Posted: 2021-11-04
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  3. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 46 of 64 (2021-03-01 to 2021-11-04)
    Posted: 2021-03-01
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  4. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 45 of 64 (2021-02-03 to 2021-03-01)
    Posted: 2021-02-03
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  5. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 44 of 64 (2020-09-01 to 2021-02-03)
    Posted: 2020-10-22
    Subject matter details: 15
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  6. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 42 of 64 (2020-09-01 to 2020-09-01)
    Posted: 2020-09-21
    Subject matter details: 15
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  7. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 43 of 64 (2020-09-01 to 2020-09-01)
    Posted: 2020-09-23
    Subject matter details: 15
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
Date Modified: